Misleading clinical evidence and systematic reviews on ivermectin for COVID-19Luis Ignacio Garegnani, Eva Madrid, Nicolás Meza
22 April 2021
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research studyRebecca Abbott, Alison Bethel, Morwenna Rogers, Rebecca Whear, Noreen Orr, Liz Shaw, Ken Stein, Jo Thompson Coon
3 June 2021
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and orangesMaria Popp, Peter Kranke, Patrick Meybohm, Maria-Inti Metzendorf, Nicole Skoetz, Miriam S Stegemann, Stephanie Weibel
20 August 2021
Getting the COVID-19 vaccine as a transplant patientMichael Mittelman
8 June 2021
Can shared decision making address COVID-19 vaccine hesitancy?Marie-Anne Durand, Peter Scalia, Glyn Elwyn
26 April 2021
Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseasesClara Locher, David Moher, Ioana Alina Cristea, Florian Naudet
30 March 2021
COVID-19 information in news media: room for greater transparencyAnisa Rowhani-Farid, Kyungwan Hong
25 February 2021
SARS-CoV-2 myocarditis: what physicians need to knowArsalan Khalil, Tamara Naneishvili, Neeraj Prasad, James Glancy
5 January 2021
Evaluating the performance of high-sensitivity troponin-T in the emergency department during the COVID-19 pandemicAli A Alsaad, Ernest Wang, Hong Lee, Mark Lampert, Philip Krause, Carl Tommaso, Gregory Mishkel, John Erwin, Christopher Boyle, Sarah Donlan, Jeremy Smiley, Mahalakshmi Halasyamani
23 September 2020
Correlation between the use of statins and COVID-19: what do we know?Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
2 December 2020